<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR32">
 <label>32.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Patick</surname>
    <given-names>AK</given-names>
   </name>
   <name>
    <surname>Brothers</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Maldonado</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Binford</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Maldonado</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Fuhrman</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Petersen</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>GJ</given-names>
    <suffix>3rd</suffix>
   </name>
   <name>
    <surname>Zalman</surname>
    <given-names>LS</given-names>
   </name>
   <name>
    <surname>Burns-Naas</surname>
    <given-names>LA</given-names>
   </name>
   <name>
    <surname>Tran</surname>
    <given-names>JQ</given-names>
   </name>
  </person-group>
  <article-title>In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease</article-title>
  <source>Antimicrob Agents Chemother</source>
  <year>2005</year>
  <volume>49</volume>
  <fpage>2267</fpage>
  <lpage>2275</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.49.6.2267-2275.2005</pub-id>
  <pub-id pub-id-type="pmid">15917520</pub-id>
 </element-citation>
</ref>
